VIAP — VIA Pharmaceuticals Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $13.92m
Annual cashflow statement for VIA Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -8.63 | -21.8 | -20.3 | -21 | -9.6 |
Depreciation | |||||
Non-Cash Items | 0.453 | 0.952 | 1.32 | 8.22 | 2.45 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.039 | 1.82 | -0.14 | 0.764 | 0.966 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -8.16 | -18.9 | -18.9 | -11.9 | -6.11 |
Capital Expenditures | -0.147 | -0.271 | -0.141 | -0.016 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 10.8 | 0 | 0.001 | 0 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.147 | 10.5 | -0.141 | -0.016 | 0 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 11.2 | 28.2 | 0 | 10 | 4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.89 | 19.8 | -19 | -1.87 | -2.11 |